Focus on: biologics that affect therapeutic agents in dermatology.

Journal of drugs in dermatology : JDD

Volumn 4, Issue 2, 2005, Pages 233-245

  Saripalli, Yamini V ^a   Gaspari, Anthony A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; INFLIXIMAB; LENERCEPT; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

DRUG ANTAGONISM; HUMAN; PHYSIOLOGY; REVIEW; SKIN DISEASE;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN HEAVY CHAINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; SKIN DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 19444382213     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)